Skip to content

Clinical trials

Cardiomyopathy, Hypertrophic trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Hypertrophic Country / region: Netherlands Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20141
20151
20182
20202
20212
20222
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status3
Terminated2
Active, not recruiting1
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cytokinetics4
Bristol-Myers Squibb2
St. Antonius Hospital2
Amsterdam UMC, location VUmc1
Gilead Sciences1
Heartcenter, University Medical Center St. Radboud1
Imbria Pharmaceuticals, Inc.1
MyoKardia, Inc.1
University of Virginia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Hypertrophic14
Angina Pectoris1
Cardiomyopathies1
Cardiomyopathy, Hypertrophic, Familial1
Dyspnea1
Heart Failure1
Hypertrophy1
Ventricular Outflow Obstruction, Left1
Ventricular Remodeling1

Trials

Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.